scispace - formally typeset
G

Gergana Zlateva

Researcher at Pfizer

Publications -  73
Citations -  3514

Gergana Zlateva is an academic researcher from Pfizer. The author has contributed to research in topics: Fibromyalgia & Pregabalin. The author has an hindex of 26, co-authored 73 publications receiving 3147 citations.

Papers
More filters
Journal ArticleDOI

The natural history and prognosis of neovascular age-related macular degeneration: a systematic review of the literature and meta-analysis.

TL;DR: A doubling of the visual angle of presenting VA may be expected to occur in the year after initial presentation in eyes with untreated neovascular AMD, and the diversity of reporting formats, paucity of long-term natural history data, and heterogeneity among the reported clinical studies impose limits to the clear understanding ofLong-term prognosis for visual function in neov vascular AMD.
Journal ArticleDOI

Minimal Clinically Important Difference in the Fibromyalgia Impact Questionnaire

TL;DR: Analysis of analyses of the Fibromyalgia Impact Questionnaire indicates that a 14% change in the FIQ total score is clinically relevant, and results of these analyses should enhance the clinical utility of the FIZ in research and practice.
Journal ArticleDOI

Burden and health care resource utilization in neovascular age-related macular degeneration: findings of a multicountry study.

TL;DR: In this paper, a cross-sectional study of 401 patients with bilateral neovascular age-related macular degeneration (NV-AMD) and 471 elderly control subjects without AMD was conducted in 5 countries.

Burden and Health Care Resource Utilization in Neovascular Age-Related Macular Degeneration

TL;DR: The evidence of extensive decline in quality of life and increased need of daily living assistance for patients with NV-AMD compared with a control population substantiates the need for new treatments that prevent vision loss and progression to blindness.